Hopital Avicenne
Bobigny, 93000, France
NCT Number: NCT06478849
The aim of this project is to evaluate, in a prospective cohort of PICC line patients, adherence to the project and understanding of the messages.
The transmission of knowledge and the acquisition of skills by patients with this type of invasive device will enable them to play an active role in their own care, and could help to reduce the frequency of risks.
This project is part of a collaborative approach that includes the creation of a mobile application for therapeutic education and monitoring (application under development). The evaluation of the device will be the subject of a national PHRC with national structures (SPIADI and PRIMO). The aim is to create a city-hospital collaboration to improve risk management.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Bobigny, 93000, France
The ever-increasing use of central venous lines, including PICC lines, and the shift in medical practice towards ambulatory care, are making it increasingly complex to prevent the infectious and non-infectious risks associated with their use.
The involvement of numerous healthcare professionals within and outside the hospital, with varying levels of training, exposes patients to numerous complications, the incidence of which, depending on the device, ranges from 6 to 16%, and occur at the time of insertion (hematoma, pneumothorax, necrosis) or during use (infection, thrombosis, extravasation).
The transmission of knowledge and the acquisition of skills by patients wearing this type of invasive device helps to make the patient a player in his or her own care, and could help to reduce the frequency of risks. As part of a therapeutic education program, we aim to validate the communication tools and messages identified by a panel of French experts. These messages, together with the article published by Petit et al, have enabled us to draw up a skills reference framework for patients with a PICC line.
The aim of this project is to evaluate adherence to the project and understanding of the messages on a prospective cohort of patients.
This project is part of a collaborative approach that includes the creation of a mobile application for therapeutic education and monitoring (application under development). The evaluation of the device will be the subject of a national PHRC with national structures (SPIADI and PRIMO). The aim is to create a city-hospital collaboration to improve risk management.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
QUESTINNAIRES / WEBINARS
Other names: WEBINARS
Time frame: WEEK 6 POST INCLUSION
The level of comprehension will be assessed on the acquisition of the main messages and will be expressed as a percentage of correct answers.
Time frame: WEEK 6 POST INCLUSION
Adherence to communication tools will be assessed by the frequency of participation in the various webinars proposed.
Time frame: week 6 post inclusion
age, gender, ethnic origin, mother language, lifestyle, place of residence...
Assistance Publique - Hôpitaux de Paris
Other
Adherence to and Understanding of a Therapeutic Education Program for Patients With Central Venous Lines
Acronym: EDUVVC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05320276
Asthma, Bronchial Diseases
Paris, France
View Trial DetailsNCT07258810
Neoplasms, Neoplasms by Histologic Type
Lyon, France
View Trial DetailsNCT06672679
Cultural Diversity, Intimate Partner Violence (IPV)
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT07417527
Behavior, Musculoskeletal Diseases
Leioa, Biscay, Spain
View Trial Details